Skip to main content
Oncotarget logoLink to Oncotarget
. 2023 Feb 25;14:149. doi: 10.18632/oncotarget.28363

Addendum: Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment

Gennady M Zharinov 1, Oleg A Bogomolov 1, Irina V Chepurnaya 1, Natalia Yu Neklasova 1, Vladimir N Anisimov 2,
PMCID: PMC9970077  PMID: 36848399

This article has an addendum: Patient consent was required and obtained. This study was approved by the Russian Research Centre of Radiology and Surgical Technologies Ethics Committee (Approval #1041Y).

Original article: Oncotarget. 2020; 11:3723–3729. 3723-3729. https://doi.org/10.18632/oncotarget.27757


Articles from Oncotarget are provided here courtesy of Impact Journals, LLC

RESOURCES